Navigation Links
Magnesium Sulfate Reduces Threat of Cerebral Palsy
Date:8/27/2008

Compound given to women at risk of preterm birth cuts risk in half, study finds

WEDNESDAY, Aug. 27 (HealthDay News) -- Magnesium sulfate, given to mothers at risk of preterm delivery, cut the rate of cerebral palsy in their babies by nearly half, a new study found.

"If deemed to be at high or immediate risk of delivery prior to 32 weeks, women and their doctors should consider using magnesium sulfate to prevent their child from having cerebral palsy," said study lead author Dr. Dwight J. Rouse, a professor of obstetrics and gynecology at the University of Alabama at Birmingham.

The findings are published in the Aug. 28 issue of the New England Journal of Medicine.

But in an editorial accompanying the study, other experts called for caution and more study before routinely recommending the treatment to prevent cerebral palsy.

In the study, the largest of its kind, Rouse and his colleagues randomly assigned 2,241 women at risk of delivering early -- between 24 and 31 weeks -- to receive either magnesium sulfate or a placebo. (Babies born after 37 to 42 weeks of pregnancy are considered full term, according to the March of Dimes.) The magnesium sulfate was given intravenously as the women entered labor as a 6-gram dose followed by a constant infusion of 2 grams per hour until either 12 hours had passed, labor had subsided, or they had given birth.

The researchers then compared infants born to each group of mothers to see if there were differences in the rates of death or the occurrence of cerebral palsy.

Cerebral palsy, marked by abnormal movement control and postures that cause limited activity, is caused by damage or dysfunction to the developing fetal or infant brain. Preterm birth is itself a risk factor for the condition. About one third of cerebral palsy cases are associated with preterm birth.

In past studies, magnesium sulfate hasn't borne out as an effective treatment for delay of early labor. But it has proven effective for treatment of maternal high blood pressure associated with pregnancy, Rouse said.

And some previous research had found magnesium sulfate effective for reducing the risk of cerebral palsy, but other studies had been inconclusive. So, Rouse and his colleagues embarked on this large, more comprehensive study.

They found no significant differences in the proportion of deaths between the magnesium sulfate group and the placebo group. But they did find that moderate or severe cerebral palsy was diagnosed in just 1.9 percent of the group treated with magnesium sulfate, compared to 3.5 percent in the placebo group.

Rouse said it's not known for certain how the compound may work. But, he said, it may "stabilize the vessels in the vulnerable preterm brain," protect against damage from lack of oxygen, and guard against injury caused by swelling and inflammation.

"Our findings are applicable only to early preterm birth," he added. "We define high risk as threatening delivery prior to 32 weeks."

Dr. William Zinser is a pediatric neurologist at Children's Medical Center, Dallas, and an associate professor of pediatric neurology at the University of Texas Southwestern Medical Center. He said, "It's too early to know if magnesium sulfate has an overall effect on the incidence rate of cerebral palsy."

Zinser reviewed the study but was not involved with it. "More research needs to be done, certainly," he said.

Rouse said women at risk for preterm birth should discuss the potential use of magnesium sulfate with their doctors.

More information

To learn more about preterm birth, visit the March of Dimes.



SOURCES: Dwight J. Rouse, M.D., professor of obstetrics and gynecology, University of Alabama at Birmingham; William Zinser, M.D., pediatric neurologist, Children's Medical Center, Dallas, and associate professor of pediatric neurology, University of Texas Southwestern Medical Center at Dallas; Aug. 28, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Magnesium May Lower Risk for Some Strokes in Male Smokers
2. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
3. ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets
4. Roxane Laboratories, Inc. Announces the Approval of Morphine Sulfate Tablets and Oral Solution
5. New study: Pine bark reduces perimenopausal symptoms
6. Different method of evaluating the urinary tract system reduces radiation dose
7. Saline Reduces Mortality for Brain Injury Patients
8. New study: Pine bark extract reduces ADHD symptoms in children
9. Radiation therapy technique reduces length of prostate cancer treatment
10. Radiation therapy technique reduces length of prostate cancer treatment
11. MR spectroscopy identifies breast cancer, reduces biopsies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The Case Management Society of America (CMSA) ... 30, 2017. CMSA’s membership has elected their upcoming President-Elect, Secretary, Treasurer and two ... position, a new VA Advisory position has also been added to the BOD, per ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... today announced the launch of a new research study, The Business Readiness Report. ... to execute that strategy, and the actual success of achieving individual and company ...
(Date:3/27/2017)... ... 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 Academic Award ... a long time,” she said. , She thinks the coming week is going to be ... I would have to help my students.” , The award will allow the 4th grade ...
(Date:3/27/2017)... Oregon (PRWEB) , ... March 27, 2017 , ... ... is pleased to announce the launch of a months-long rebranding effort. This includes ... formulations. , “Through focus group discussions and market research, we learned that a ...
(Date:3/27/2017)... ... 27, 2017 , ... The homeowner improvement and repair market is expected to ... unlicensed contractors for renovations is also on the rise. Per a 2017 report, 13% ... those, 42% failed to use a licensed contractor.(2) The risks associated with improper renovations—especially ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... --  Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical ... today announced that it has added two experts in the ... its Scientific Advisory Board . The two ... , MD, former chief of the Pediatric Pulmonary and Allergy ... Stanford University, and David Denning , ...
(Date:3/27/2017)... 2017 On Friday, benchmark US ... closed the trading session up 0.19%; the Dow Jones ... was down 0.08%. US markets made broad based gains ... in green. Pre-market today, Stock-Callers.com reviews these four Medical ... WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: ...
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. (NASDAQ: ... Paul M. Bisaro as Impax,s President and ... Board, effective March 27, 2017. Mr. Bisaro will succeed ... Interim President and Chief Executive Officer since December of ... and branded pharmaceutical experience, Mr. Bisaro, 56, is an ...
Breaking Medicine Technology: